1URIELI-SHOVAL S,COHEN P, EISENBERG S, et al.Widespread expression of serum amyloid A in histologically normal human tissues: predominant localization to the epithelium[J]. J Histoehem Cytochem, 1998,46:1377-1384.
2URIELI-SHOVAL S,LINKE R P,MATZNER Y. Expression and function of serum amyloid A(SAA),a major acute phase protein,in normal and disease states[J].Curr Opin Hematol,2000, 7:64-69.
3MEEK R L, URIELI-SHOVAL S, BENDITT E P. Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function[J].Proc Natl Acad Sci USA, 1994,91:3186-3190.
4MORROW D A, RIFAI N, ANTMAN E M, et al. Serum amyloid A predicts early mortality in acute coronary syndromes: a TIMI 11A substudy[J]. J Am Coll Cardio,2000,35: 358-362.
5WHITE H D,BRAUNWAI. D. Applying the open artery theory: use of predictive survival markers[J]. Eur Heart J,1998, 19:1132-1139.
6HOFFMEISTER A, ROTHENBACHER D, BAZNER U,et al. Role of novel markers of inflammation in patients with stable coronary heart disease[J]. Am J Cardial,2001, 87:262-266.
7JOHNSON B D,KIP K E, MARROQUIN O C,et al.Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women:the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE) [J]. Circulation,2004, 109:726-732.
8RIDKER P M,HENNEKENS C H,BURING J E,et al.C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women[J].New Engl J Med,2000, 342:836-843.
9MASHIBA S, OGASAWARA K, TAKEYA M, et al. Development of blood examination method of serum amyloid A and LDL complex, and clinical application to predieition of cardiovascular event[J]. Rinsho Byori, 2004,52:67-74.
10MAJOR A S, DOVE D E, ISHIGURO H, et al. Increased cholesterol efflux in apolipoprotein AI (apoAI)-producing macrophages as a mechanism for reduced atherosclerosis in apoAI (-/-) mice [J]. Arterioscler Thromb Vase Biol, 2001, 21:1790-1795.
6urieli-Shoval S,Linke RP,Matzner Y.Expression and function of serum amyloid A,a major acute-phase protein,in normal and disease states.Curr Opin Hematol,2000,7:64-69.
7d'Eril GM, Anesi A, Maggiore M, et al. Biological variation of serum amyloid A in healthy subjects. Clin Chem, 2001, 47: 1498-1499.
8Delanghe JR, Langlois MR, De Bacquer D, et al. Discriminative value of serum amyloid A and other acute- phase proteins for coronary heart disease. Atherosclerosis, 2002, 160: 471-476.
9National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis, 2002, 39( 2 Suppl 1): S1-S266.
10Levy D, Anderson KM, Savage DD, et al Echocardiographically detected left ventricular hypertrophy prevalence and risk factors. The Framingham Heart Study Ann Intern Med, 1988, 108: 7-13.
